16616241

Source:http://linkedlifedata.com/resource/pubmed/id/16616241

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0011777, umls-concept:C0025936, umls-concept:C0042449, umls-concept:C0087111, umls-concept:C0205400, umls-concept:C0332835
pubmed:issue	4
pubmed:dateCreated	2006-4-17
pubmed:abstractText	The aim of this study was to assess whether the anti-inflammatory agent dexamethasone can inhibit vein graft thickening without the occurrence of serious side effects.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8407742
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein E3, http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins E, http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/apolipoprotein E3 (Leidein)
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0741-5214
pubmed:author	pubmed-author:EeftingDanielD, pubmed-author:PiresNuno M MNM, pubmed-author:QuaxPaul H APH, pubmed-author:SchepersAbbeyA, pubmed-author:de VriesMargreet RMR, pubmed-author:van BockelJ HajoJH
pubmed:issnType	Print
pubmed:volume	43
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	809-15
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:16616241-Animals, pubmed-meshheading:16616241-Apolipoprotein E3, pubmed-meshheading:16616241-Apolipoproteins E, pubmed-meshheading:16616241-Atherosclerosis, pubmed-meshheading:16616241-Base Sequence, pubmed-meshheading:16616241-Dexamethasone, pubmed-meshheading:16616241-Disease Models, Animal, pubmed-meshheading:16616241-Drug Administration Schedule, pubmed-meshheading:16616241-Endothelium, Vascular, pubmed-meshheading:16616241-Graft Occlusion, Vascular, pubmed-meshheading:16616241-Graft Rejection, pubmed-meshheading:16616241-Graft Survival, pubmed-meshheading:16616241-Humans, pubmed-meshheading:16616241-Hypercholesterolemia, pubmed-meshheading:16616241-Male, pubmed-meshheading:16616241-Mice, pubmed-meshheading:16616241-Mice, Inbred C57BL, pubmed-meshheading:16616241-Mice, Transgenic, pubmed-meshheading:16616241-Molecular Sequence Data, pubmed-meshheading:16616241-RNA, Messenger, pubmed-meshheading:16616241-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:16616241-Risk Assessment, pubmed-meshheading:16616241-Saphenous Vein, pubmed-meshheading:16616241-Sensitivity and Specificity, pubmed-meshheading:16616241-Treatment Outcome, pubmed-meshheading:16616241-Vascular Surgical Procedures
pubmed:year	2006
pubmed:articleTitle	Short-term dexamethasone treatment inhibits vein graft thickening in hypercholesterolemic ApoE3Leiden transgenic mice.
pubmed:affiliation	Gaubius Laboratory, TNO Quality of Life, Leiden University Medical Center, The Netherlands.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't